L
ymphedema is the chronic, progressive swelling of tissue caused by inadequate lymphatic function. Lymphedema may result from anomalous development (primary) or injury (secondary) to lymph nodes or lymphatic vessels. Although lymphedema is a specific condition, children with a large lower limb are often labeled as having lymphedema, regardless of the underlying cause. Because lymphedema is much more prevalent in the general population than other potential causes of congenital lower extremity overgrowth, referring physicians likely are most familiar with the term "lymphedema." Lymphedema, however, is typically an adult disease caused by lymphadenectomy and/or irradiation to the axilla or groin. Primary pediatric lymphedema is rare; a child erroneously diagnosed with lymphedema may undergo unnecessary tests and be given incorrect treatment. The purposes of this study were to determine the accuracy of the term "lymphedema" for pediatric lower limb enlargement and to document other causes with which it is frequently confused.
PATIENTS AND METHODS
After approval from the Committee on Clinical Investigation at Children's Hospital Boston, our Vascular Anomalies Center database was reviewed for patients sent between 1999 and 2010 labeled with lower extremity "lymphedema." Individuals with disease onset after 21 years of age were excluded to ensure that only a pediatric cohort was studied. The correct diagnosis was determined by history, physical examination, photographs, imaging studies, and/or histopathology. Alternative conditions, sex, and age-of-onset were recorded. The Mann-Whitney U test was used to differentiate age of onset between patients with lymphedema and children with other disorders. Age of onset was defined in years and, if present before 12 months of age, was recorded as 0. Results are presented as median with interquartile range (25th to 75th percentile). A two-tailed value of p Ͻ 0.05 was considered significant. Statistical analysis was performed using the SPSS software package (version 16.0; SPSS, Inc., Chicago, Ill.).
RESULTS
A referral diagnosis of lower extremity lymphedema was identified in 170 children of 9477 patients in the database (1.8 percent). Lymphedema was confirmed in 124 patients (72.9 percent). The remaining 27.1 percent (46 of 170) of patients referred with lymphedema had a different diagnosis (Table 1) 
DISCUSSION
Lymphedema is an often loosely used label for an enlarged lower extremity in children, regardless of the cause. Lymphedema is a precise term that defines chronic, progressive swelling of subcutaneous tissue caused by abnormal development or injury to the lymphatic vasculature. Primary lymphedema most commonly affects the lower extremity (Fig. 1) . Patients have a significant risk of infection, and limb enlargement occurs over time from adipose deposition and fibrosis. Lymphedema can be differentiated from other causes of extremity overgrowth by history and physical examination in approximately 90 percent of patients. The foot is always involved and swelling proceeds proximally. Edema becomes less pitting over time as adipose and fibrous tissue are deposited. 1 Definitive diagnosis of lymphedema requires lymphoscintigraphy, which is 92 percent sensitive and 100 percent specific for the disorder. 2 Compromised lymphatic function is illustrated by delayed transit and/or cutaneous accumulation (dermal backflow) of radiolabeled colloid injected into the feet.
Management of lymphedema requires daily washing and moisturizing of the extremity to minimize desiccation, skin breakdown, and subsequent cellulitis. Patients should wear protective clothing to prevent incidental trauma, which also can lead to infection. Compression therapy using a custom-fitted garment and a pneumatic pump helps to reduce the volume of the extremity and slow progression. Patients with significant morbidity who have failed conservative treatment may be considered for contour resection. We prefer suction-assisted lipectomy for moderately enlarged extremities and staged skin/subcutaneous resection for patients with major overgrowth and skin excess. [3] [4] [5] [6] Approximately one-fourth of patients labeled with lymphedema referred to our center had another condition. The most commonly confused diagnoses were other vascular anomalies: single-vessel forms (capillary malformation, lymphatic malformation, venous malformation), combined malformations (capillary-venous, lymphatic-venous), and eponymous syndromes (Klippel-Trenaunay, Parkes Weber). It is important to separate these conditions from lymphedema because their natural history, prognosis, and treatment are very different. Like lymphedema, vascular anomalies are diagnosed by history and physical examination in at least 90 percent of patients. Although primary lymphedema can present at birth, it also may develop later in childhood or in adolescence. In contrast, most vascular anomalies are obvious during infancy. Girls are not more likely to have lymphedema than boys; therefore, sex should not be considered when differentiating lymphedema from other conditions. If the diagnosis remains equivocal following history and physical examination, lymphoscintigraphy will rule out lymphedema, and magnetic resonance imaging can confirm the diagnosis of another vascular anomaly.
Diffuse capillary malformation with overgrowth can cause soft-tissue and skeletal enlargement of a limb (Fig. 2) . Patients are not at increased risk for infection, and the progression of overgrowth is slow. The cutaneous stain is treated by pulsed-dye laser. The circumferential overgrowth may be improved with suction-assisted lipectomy; occasionally, axial enlargement can cause a leg-length discrepancy.
Venous and noneponymous combined malformations (e.g., capillary-venous, lymphatic-venous) are localized in more than 90 percent of patients; 50 percent affect deep structures (e.g., muscle, bone, joints, viscera) (Figs. 2 and 3). 7, 8 One-half of sporadic venous malformations have a somatic mutation in the TIE2 receptor. 8 Venous malformations of the lower limb typically involve the skin and/or muscles. If all tissues, including Volume 127, Number 4 • Pediatric Lower Limb Enlargement bone, are affected, the disorder is called phlebectasia of Bockenheimer. 9 Extremity venous malformation can cause leg-length discrepancy, hypoplasia resulting from disuse atrophy, fibrosis, pain, pathologic fracture, hemarthrosis, and degenerative arthritis. 10, 11 A large venous malformation involving the deep venous system is at risk for thrombosis and pulmonary embolism. Stagnation within a lesion can cause localized intravascular coagulopathy and painful phlebothromboses.
Treatment of lower extremity venous malformation includes compression garments, sclerotherapy, and/or resection.
Primary lymphedema differs from microcystic, macrocystic, and combined lymphatic malformations because it is not cystic and involves only the subcutaneous layer. Microcystic/macrocystic lymphatic malformation can affect all structures of the extremity, including muscle and bone (Fig. 2) . Several germ-line mutations cause Plastic and Reconstructive Surgery • April 2011 primary lymphedema (VEGFR3, FOXC2, SOX18, and CCBE1). [12] [13] [14] [15] In contrast, microcystic/macrocystic lymphatic malformations are thought to result from paradominant inheritance; an individual with a predisposed inherited mutation develops a somatic second hit in the same gene that causes expression of the lesion. 16 Symptomatic microcystic/macrocystic lymphatic malformations of the lower extremity are managed by compression, sclerotherapy, and/or resection.
The eponymous vascular malformations, KlippelTrenaunay and Parkes Weber syndrome, usually are more problematic than lymphedema (Fig. 4) . Klippel-Trenaunay syndrome is a capillary-lymphatic-venous malformation of the lower extremity with overgrowth. Patients are at risk for infections, deep venous thrombosis, pulmonary embolism, leg-length discrepancy, and difficulty with ambulation. Large embryonal veins are removed to prevent venous thrombosis. A shoe lift or epiphysiodesis may be necessary to correct leg-length discrepancy. Occasionally, selective amputation is required to permit footwear and to facilitate ambulation. Soft-tissue overgrowth can be improved with staged skin/subcutaneous resection. Parkes Weber syndrome is a capillary-arteriovenous or capillary-lymphatic-arteriovenous malformation of the lower extremity with overgrowth. Parkes Weber syndrome can be caused by a mutation in RASA1, and patients with multiple capillary malformations are likely on the spectrum of capillary malformation-arteriovenous malformation. 17 Patients are at risk for congestive heart failure because of extensive arteriovenous shunting. Genetic counseling is required for children with capillary malformation-arteriovenous malformation because it is an autosomal dominant condition. Symptomatic patients are managed by embolization; epiphysiodesis or amputation may be necessary.
Lipedema is commonly misdiagnosed as lymphedema (Fig. 5) . It is characterized by bilateral, fatty hypertrophy of the lower extremities in disproportion to the rest of the body. 18 Pubertal female patients are primarily affected, and a positive family history may be reported. Unlike lymphedema, the foot is not involved, pain is common, and patients are not at an increased risk for infection. Lipedema can be differentiated from lymphedema by history and physical examination. Magnetic resonance imaging shows increased subcutaneous adipose tissue without stranding or thickened skin; lymphoscintigraphy is normal. The size of the limb can be reduced by suctionassisted lipectomy. 
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Hemihypertrophy, the idiopathic enlargement of an area compared with the contralateral side, may be confused with lymphedema (Fig. 6 ). 19 Hemihypertrophy is usually a diagnosis of exclusion. Lymphoscintigraphy is normal and magnetic resonance imaging demonstrates enlargement of all components of the extremity (i.e., adipose, muscle, bone) without pathologic findings. Unlike lymphedema, there is overgrowth of the tissues below the muscle fascia. Occasionally, symmetry may be improved with suction-assisted lipectomy of the subcutaneous compartment. In contrast to other causes of extremity overgrowth, children with hemihypertrophy are at risk for Wilms tumor and require screening. 20 A lower extremity tumor can be mistaken for lymphedema (Fig. 7) . Infantile hemangioma, the most common tumor of infancy, is usually localized and easily distinguished from lymphedema. A diffuse, reticular form may involve the lower extremity and present with hypertrophy. 21 Reticular hemangioma is differentiated from lymphedema because it appears shortly after birth, proliferates, and then involutes. The tumor is infiltrative and can involve fascia or muscle. In addition, reticular hemangioma often ulcerates and is associated with ventral-caudal malformative anomalies. 21 Management may require corticosteroid treatment for recalcitrant ulceration or congestive heart failure; imaging is necessary to rule out underlying structural disorders.
Kaposiform hemangioendothelioma is a rare vascular neoplasm that is locally aggressive but does not metastasize. 22, 23 Although one-half of le- Plastic and Reconstructive Surgery • April 2011
sions are present at birth, onset can occur in infancy or childhood. 24 The tumor is often diffuse, and an extremity is affected in approximately onethird of patients. 24, 25 The skin is reddish purple and pain is common. In addition, 50 percent of patients have Kasabach-Merritt phenomenon [thrombocytopenia (Ͻ25,000/mm 3 ), petechiae, bleeding]. 22, 26, 27 Kaposiform hemangioendothelioma enlarges in early childhood and then partially regresses after 2 years of age into mid childhood. Usually, there is residual tumor and fibrosis that causes chronic pain and stiffness. 28 Kaposiform hemangioendothelioma also has a lymphatic component, which stains positive for the lymphatic marker D2-40. 25 First-line treatment is vincristine to control Kasabach-Merritt phenomenon and pain; resection is rarely possible because the tumor involves multiple tissue planes and important structures. 29 Lipofibromatosis is a rare, slow-growing neoplasm that, when diffuse, can cause enlargement of the lower limb. 30, 31 It is not aggressive and does not metastasize. The leg usually is enlarged at birth or by early childhood; subcutaneous fatty overgrowth is the predominant finding. Lipofibromatosis can involve the subfacial compartments and cause bony overgrowth; the foot may be spared. Diagnosis is confirmed by histopathologic examination showing abundant adipose tissue, spindled fibroblasts, focal fascicular growth, and limited mitotic activity. 30, 31 Suction-assisted lipectomy can improve limb contour. 31 Posttraumatic swelling is erroneously labeled lymphedema in some children. Prolonged edema of the lower extremity can occur following injury, particularly after a severe sprain or fracture. Unlike lymphedema, the lymphatic function of the extremity is normal. If the diagnosis is equivocal, lymphoscintigraphy will demonstrate intact lymphatic flow. Some patients will have a ligamentous tear or small fracture that can be identified by plain film and/or magnetic resonance imaging.
Rarely, rheumatologic disorders can cause chronic lower extremity swelling in children. Lymphedema and other conditions are ruled out by lymphoscintigraphy and magnetic resonance imaging. If there is no history of trauma and no other potential cause of the swelling can be Volume 127, Number 4 • Pediatric Lower Limb Enlargement Additional conditions may cause lower extremity asymmetry in children but were excluded from this study because patients were not erroneously diagnosed with lymphedema (Fig. 8) . For example, CLOVES syndrome (congenital lipomatosis overgrowth, vascular malformations, epidermal nevi, and scoliosis) represents a newly described overgrowth disorder. 32, 33 Rare vascular tumors, such as nonkaposiform hemangioendotheliomas can involve the lower limb. Finally, conditions that reduce the size of one lower extremity, such as hemiatrophy, may cause the contralateral limb to appear enlarged.
CONCLUSIONS
Approximately one-fourth of pediatric patients with a large lower extremity are misdiagnosed as having lymphedema. The most commonly confused causes are other types of vascular anomalies, lipedema, and hemihypertrophy. Although history and physical examination usually are sufficient to differentiate lymphedema from other conditions, lymphoscintigraphy and/or magnetic resonance imaging may be necessary if the cause is unclear (Table 2 and Fig. 9 ). If lymphedema is suspected, a lymphoscintigram is *Capillary malformation, lymphatic malformation, venous malformation, combined vascular malformation (e.g., lymphatic-venous malformation, Klippel-Trenaunay syndrome, Parkes Weber syndrome, CLOVES syndrome). †Infantile hemangioma, kaposiform hemangioendothelioma, lipofibromatosis. ‡Posttraumatic, rheumatologic, and systemic fluid overload (e.g., cardiac, hepatic, renal disease).
Volume 127, Number 4 • Pediatric Lower Limb Enlargement the first imaging test ordered. A patient thought to have a condition other than lymphedema on history and physical examination usually undergoes magnetic resonance imaging evaluation to confirm the suspected diagnosis and/or to define the extent of disease. Magnetic resonance imaging also is commonly used as a secondary imaging study if lymphoscintigraphy is negative. Correct diagnosis is important because the natural history and management of lymphedema are very different compared with other lower extremity diseases in children.
